PATENT CLAIM ANALYSIS

Application Number: 15781351
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["424", "502000"]

Abstract:
The invention relates to a composition comprising solid lipid nanoparticles (SLNs), wherein the SLNs comprise an aminoalkyl glucosaminide phosphate (AGP).

Claim (Index 2):
The composition of  claim 1 , wherein the AGP is a TLR4 agonist.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.13043
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14777091', '14371338', '14894505', '14426036', '13543493']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7092066770253482
- 35 USC 102 Novelty (BERT): 0.5122802792696143
- Combined Prediction Score: 0.6895140372497749
- Mean Citation Score: 132.063779
- Max Citation Score: 153.38156
- Similarity Product: 76.94956062470914

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test